December 27, 2019
1 min read

Study shows vision therapy does not improve reading in convergence insufficiency

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Children with a diagnosis of symptomatic convergence insufficiency saw no additional improvement in reading comprehension with office-based vergence/accommodation therapy compared with office-based placebo therapy, according to findings published in Optometry and Vision Science.

Members of the Convergence Insufficiency Treatment Trial — Attention and Reading Trial (CITT-ART) evaluated the effect of office-based vergence/accommodative therapy on reading performance in 310 children 9 to 14 years old with symptomatic convergence insufficiency.

The children were randomized to receive 16 weeks of either office-based vergence/accommodative therapy or office-based placebo therapy, and the primary outcome was change in reading comprehension on the Wechsler Individual Achievement Test, third edition (WIAT-III).

The investigators found that the adjusted mean improvement in WIAT-III reading comprehension was 3.7 (95% CI, 2.6-4.7) in the vergence/accommodative therapy group and 3.8 (95% CI, 2.4-5.2) in the placebo group. There was an adjusted mean group difference of -0.12 (95% CI, -1.89 to 1.66) that was not statistically significant, they said.

“While in-office therapy can improve visual function for children with [convergence insufficiency], this trial indicates that clinicians should not suggest that it will lead to increased reading performance,” co-author Mitchell Scheiman, OD, PhD, said in a press release. – by Earl Holland Jr.

Disclosures: The authors report no relevant financial disclosures.